T1 mapping – Medxy AI

Normal T1 Mapping Values Rule Out Adverse Cardiovascular Events in Fabry Cardiomyopathy: A New Multimodal Prognostic Score

By MedXY 01/05/2026

A prospective study of 167 Fabry disease patients identifies low T1 values, left ventricular hypertrophy, and late gadolinium enhancement as key predictors of major adverse cardiac events, leading to a robust new 3-year clinical prognostic score.

Cardiology Nephrology news

A New Frontier in Fabry Cardiomyopathy: Validating a T1-Inclusive Prognostic Score for Cardiovascular Risk

By MedXY 01/05/2026

This article explores a novel 3-year prognostic score for Fabry Disease cardiomyopathy, integrating CMR-derived T1 values, LV mass, and LGE extent to predict adverse events, emphasizing the negative predictive value of normal T1 mapping.

Cardiology Clinical Updates news Radiology Specialties

Myocardial T1 Mapping and Extracellular Volume: Emerging Prognostic Tools in Heart Failure and Non-Ischaemic Dilated Cardiomyopathy

By MedXY 09/03/2025

Cardiac MRI T1 mapping and extracellular volume fraction (ECV) provide noninvasive markers of myocardial fibrosis, showing consistent prognostic value across heart failure subtypes and non-ischaemic dilated cardiomyopathy for adverse cardiovascular outcomes.